Skip to main content
. 2019 Mar 21;2019:5829676. doi: 10.1155/2019/5829676

Table 2.

Odds ratios for risk of HPV persistence of active smokers and secondhand smokers according to alcohol drinking status.

HR-HPV infection at enrollmenta (n = 4,578) 1-year HR-HPV persistenceb (n = 527) 2-year HR-HPV persistenceb (n = 205)
Alcohol drinkers Negative Positive Multivariate OR Negative Persistence Multivariate OR Negative Persistence Multivariate OR
(n = 4,059) (n = 519) (95% CI)e (n = 447) (n = 80) (95% CI) e (n = 177) (n = 28) (95% CI) e

Active tobacco smoking
 Nonsmoking 3527 (88.9) 440 (11.1) 1 (ref.) 386 (84.8) 69 (15.2) 1 (ref.) 144 (84.7) 26 (15.3) 1 (ref.)
 Smoking 532 (87.1) 79 (12.9) 1.14 (0.88–1.49) 2) 61 (84.7) 11 (15.3) 0.92 (0.45–1.92) 33 (94.3) 2 (5.7) 0.30 (0.07–1.43)
  p for interactionf 0.072 3) 0.586 0.257
Secondhand smoking (SHS)
 Non-SHS 2402 (89.4) 285 (10.6) 1 (ref.) 250 (86.5) 39 (13.5) 1 (ref.) 98 (88.3) 13 (11.7) 1 (ref.)
 SHS c 1657 (87.6) 234 (12.4) 1.25 (1.06–1.47) 197 (82.8) 41 (17.2) 1.64 (1.09–2.48) 79 (84.0) 15 (16.0) 2.54 (1.25–5.17)
  p for interactionf 0.005 0.012 0.029
SHS in nonactive smokers
 Non-SHS 2092 (89.7) 240 (10.3) 1 (ref.) 218 (86.9) 33 (13.1) 1 (ref.) 82 (87.2) 12 (12.8) 1 (ref.)
 SHS d 1435 (87.8) 200 (12.2) 1.25 (1.05–1.48) 168 (82.4) 36 (17.6) 1.75 (1.14–2.68) 62 (81.6) 14 (18.4) 2.96 (1.42–6.15)
  p for interactionf 0.003 0.004 0.006

HR-HPV infection at enrollmenta (n =4,652 ) 1-year HR-HPV persistenceb (n =639) 2-year HR-HPV persistenceb (n =252)
Alcohol nondrinkers Negative Positive Multivariate OR Negative Persistence Multivariate OR Negative Persistence Multivariate OR
(n = 4,242) (n = 410) (95% CI) (n = 580) (n = 59) (95% CI) (n = 231) (n = 21) (95% CI)

Active tobacco smoking
 Nonsmoking 4076 (91.3) 387 (8.7) 1 (ref.) 555 (91.0) 55 (9.0) 1 (ref.) 222 (91.7) 20 (8.3) 1 (ref.)
 Smoking 166 (87.8) 23 (12.2) 1.26 (0.81–1.96) 25 (86.2) 4 (13.8) 1.20 (0.39–3.65) 9 (90.0) 1 (10.0) 0.89 (0.11–7.48)
Secondhand smoking (SHS)
 Non-SHS 2806 (91.0) 279 (9.0) 1 (ref.) 379 (89.4) 45 (10.6) 1 (ref.) 137 (89.5) 16 (10.5) 1 (ref.)
 SHS c 1436 (91.6) 131 (8.4) 0.70 (0.56–0.87) 201 (93.5) 14 (6.5) 0.40 (0.21–0.77) 94 (95.0) 5 (5.0) 0.52 (0.20–1.39)
SHS in nonactive smokers
 Non-SHS 2701 (91.1) 265 (8.9) 1 (ref.) 361 (89.6) 42 (10.4) 1 (ref.) 134 (89.9) 15 (10.1) 1 (ref.)
 SHS d 1375 (91.8) 122 (8.2) 0.78 (0.64–0.95) 194 (93.7) 13 (6.3) 0.43 (0.23–0.77) 88 (94.6) 5 (5.4) 0.49 (0.19–1.29)

a Enrollment HR-HPV infection indicates the HR-HPV infection at the time of enrollment. “Negative” or “Positive” indicates the result of detection for 13 DNA types of high risk-human papillomavirus (HR-HPV) (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68) using Hybrid Capture II.

b One-year and 2-year HR-HPV persistence were defined as HPV positivity in the 1-year follow-up study year and as HPV positivity in both the 1- and 2-year follow-up study years, respectively, after enrollment with HR-HPV positivity. One- and 2-year HPV negatives were defined as HPV negativity in the 1-year follow-up study year and as HPV negativity in both the 1- and 2-year follow-up study years, respectively, after enrollment with HPV negativity.

c Non-SHS indicates persons who are not exposed to secondhand smoking at home or in the workplace, regardless of active smoking status.

d Secondhand smoking (SHS) in nonsmokers was defined as having never smoked in life but having been exposed to SHS.

e All variables were adjusted for age, BMI, marital status, oral contraceptive use, menopausal status, education level, and number of children.

f The p value represents the multiplicative interaction of two factors.